Executive Summary of the II Brazilian Guidelines for Atrial Fibrillation.
作者信息
Magalhães Luiz Pereira de, Figueiredo Marcio Jansen de Oliveira, Cintra Fatima Dumas, Saad Eduardo Benchimol, Kuniyoshi Ricardo Ryoshim, Menezes Lorga Filho Adalberto, D'Avila Andre Luiz Buchele, Paola Angelo Amato Vincenzo de, Kalil Carlos Antonio Abunader, Moreira Dalmo Antonio Ribeiro, Sobral Filho Dario Celestino, Sternick Eduardo Back, Darrieux Francisco Carlos da Costa, Fenelon Guilherme, Lima Gustavo Glotz de, Atié Jacob, Mateos José Carlos Pachón, Moreira José Marcos, Vasconcelos José Tarcísio Medeiros de
机构信息
Sociedade Brasileira de Arritmias Cardíacas, São Paulo, SP, Brazil.
出版信息
Arq Bras Cardiol. 2016 Dec;107(6):501-508. doi: 10.5935/abc.20160190.
Abstract
摘要
相似文献
1
Executive Summary of the II Brazilian Guidelines for Atrial Fibrillation.《巴西房颤指南（第二版）》执行摘要
Arq Bras Cardiol. 2016 Dec;107(6):501-508. doi: 10.5935/abc.20160190.
2
Management of atrial fibrillation.心房颤动的管理。
Med Clin North Am. 2015 Jul;99(4):781-94. doi: 10.1016/j.mcna.2015.02.007. Epub 2015 Apr 11.
3
Pharmacological therapy following catheter ablation of atrial fibrillation.房颤导管消融术后的药物治疗。
J Cardiovasc Med (Hagerstown). 2012 Jan;13(1):9-15. doi: 10.2459/JCM.0b013e32834d5880.
4
Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.阵发性心房颤动、中风风险与血栓预防
Thromb Haemost. 2008 Jul;100(1):11-3. doi: 10.1160/TH08-05-0331.
5
Periprocedural antithrombotic management of patients undergoing ablation for atrial fibrillation: what we currently do...and what should we do?心房颤动消融患者围手术期的抗栓管理：我们目前所做的……以及我们应该做什么？
Can J Cardiol. 2013 Feb;29(2):139-41. doi: 10.1016/j.cjca.2012.05.016. Epub 2012 Jul 20.
6
Antiarrhythmic therapy following ablation of atrial fibrillation.心房颤动消融术后的抗心律失常治疗。
Expert Rev Cardiovasc Ther. 2013 Jul;11(7):837-42. doi: 10.1586/14779072.2013.811982.
7
Is ablation to termination the best strategy for ablation of persistent atrial fibrillation? Ablation to termination is not the best strategy during ablation.对于持续性心房颤动的消融，消融至终止是最佳策略吗？在消融过程中，消融至终止并非最佳策略。
Circ Arrhythm Electrophysiol. 2015 Aug;8(4):972-80. doi: 10.1161/CIRCEP.115.001722.
8
Atrial fibrillation: food for thought in 2013.心房颤动：2013年值得思考的问题。
Am J Med. 2013 Nov;126(11):937-8. doi: 10.1016/j.amjmed.2013.02.038.
9
Feasibility and safety of outpatient radiofrequency catheter ablation procedures for atrial fibrillation.门诊射频导管消融术治疗心房颤动的可行性和安全性。
Postgrad Med J. 2010 Jul;86(1017):395-8. doi: 10.1136/pgmj.2009.092510.
10
Safety of dabigatran or rivaroxaban for thoracoscopic ablation in patients with atrial fibrillation.达比加群或利伐沙班用于房颤患者胸腔镜消融术的安全性。
Int J Cardiol. 2015;186:213-5. doi: 10.1016/j.ijcard.2015.03.229. Epub 2015 Mar 18.
引用本文的文献
1
Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology - 2024.巴西心脏病学会2024年围手术期心血管评估指南。
Arq Bras Cardiol. 2024 Oct 21;121(9):e20240590. doi: 10.36660/abc.20240590.
2
Atrial Fibrillation in Endurance Training Athletes: Scoping Review.耐力训练运动员的心房颤动：范围综述
Rev Cardiovasc Med. 2023 May 26;24(6):155. doi: 10.31083/j.rcm2406155. eCollection 2023 Jun.
3
A Nationwide Initiative to Improve Cardiology Quality: The Best Practice in Cardiology Program in Brazil.一项旨在提高心脏病学质量的全国性倡议：巴西心脏病学最佳实践计划。
Arq Bras Cardiol. 2023 Nov;120(10):e20230375. doi: 10.36660/abc.20230375.
4
Percutaneous left atrial appendage closure: beyond the classic indications.经皮左心耳封堵术：超越经典适应症
AsiaIntervention. 2023 Mar 15;9(1):70-77. doi: 10.4244/AIJ-D-22-00040. eCollection 2023 Mar.
5
Circulating MicroRNAs as Specific Biomarkers in Atrial Fibrillation: A Meta-Analysis.循环微小RNA作为心房颤动的特异性生物标志物：一项荟萃分析。
Noncoding RNA. 2023 Feb 9;9(1):13. doi: 10.3390/ncrna9010013.
6
Rhythm Control Interventions in Patients with Atrial Fibrillation - Insights on Preprocedural Anticoagulation and Utility of Left Atrial Imaging.心房颤动患者的节律控制干预——术前抗凝及左心房成像效用的见解
Arq Bras Cardiol. 2022 Oct;119(4):520-521. doi: 10.36660/abc.20220663.
7
Atrial Flutter in PRKAG2 Syndrome: Clinical and Electrophysiological Characteristics.PRKAG2综合征中的心房扑动：临床及电生理特征
Arq Bras Cardiol. 2022 Sep 12;119(5):681-8. doi: 10.36660/abc.20210792.
8
Reconnection of Pulmonary Veins After Ablation. A Challenge to be Overcome.消融术后肺静脉再连接：一项有待克服的挑战
Arq Bras Cardiol. 2021 Jul;117(1):106-107. doi: 10.36660/abc.20210438.
9
Atrial Fibrillation (Part 2) - Catheter Ablation.心房颤动（第二部分）-导管消融。
Arq Bras Cardiol. 2021 Feb;116(2):334-343. doi: 10.36660/abc.20200477.
10
The legacy of Prof. Eduardo Sosa.爱德华多·索萨教授的遗产。
Arq Bras Cardiol. 2020 Nov;115(5):801-806. doi: 10.36660/abc.20201080.
本文引用的文献
1
Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial.应用接触力感应导管的阵发性房颤导管消融术：前瞻性、多中心 SMART-AF 试验的结果。
J Am Coll Cardiol. 2014 Aug 19;64(7):647-56. doi: 10.1016/j.jacc.2014.04.072.
2
Low incidence of permanent complications during catheter ablation for atrial fibrillation using open-irrigated catheters: a multicentre registry.使用冷盐水灌注导管行导管消融治疗心房颤动的永久性并发症发生率低：一项多中心注册研究。
Europace. 2014 Aug;16(8):1154-9. doi: 10.1093/europace/euu002.
3
Comparison of the change in the dimension of the pulmonary vein ostia immediately after pulmonary vein isolation for atrial fibrillation-open irrigated-tip catheters versus non-irrigated conventional 4 mm-tip catheters.房颤治疗中，采用开放式灌注尖端导管与非灌注传统4毫米尖端导管进行肺静脉隔离后，即刻对比肺静脉口尺寸的变化。
J Interv Card Electrophysiol. 2014 Oct;41(1):83-90. doi: 10.1007/s10840-014-9919-6. Epub 2014 Jul 16.
4
Epidemiology of atrial fibrillation: European perspective.心房颤动的流行病学：欧洲视角。
Clin Epidemiol. 2014 Jun 16;6:213-20. doi: 10.2147/CLEP.S47385. eCollection 2014.
5
The role of prothrombin complex concentrates in reversal of target specific anticoagulants.凝血酶原复合物浓缩物在逆转靶向特异性抗凝剂中的作用。
Thromb J. 2014 Apr 17;12:8. doi: 10.1186/1477-9560-12-8. eCollection 2014.
6
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南：执行摘要：美国心脏病学会/美国心脏协会实践指南工作组和心律学会的报告
Circulation. 2014 Dec 2;130(23):2071-104. doi: 10.1161/CIR.0000000000000040. Epub 2014 Mar 28.
7
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.射频消融与抗心律失常药物作为阵发性心房颤动（RAAFT-2）一线治疗的比较：一项随机试验。
JAMA. 2014 Feb 19;311(7):692-700. doi: 10.1001/jama.2014.467.
8
Surgical options for treatment of atrial fibrillation.治疗心房颤动的手术选择。
Ann Cardiothorac Surg. 2014 Jan;3(1):30-7. doi: 10.3978/j.issn.2225-319X.2014.01.07.
9
Two-staged hybrid treatment of persistent atrial fibrillation: short-term single-centre results.持续性心房颤动的两阶段混合治疗：单中心短期结果
Interact Cardiovasc Thorac Surg. 2014 Apr;18(4):451-6. doi: 10.1093/icvts/ivt538. Epub 2014 Jan 12.
10
Edoxaban versus warfarin in patients with atrial fibrillation.依度沙班与华法林用于房颤患者。
N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.
Zotero 插件